Driving a New Generation of Cell-based Medicines

2020 Webinar Series

Flexible, clinically adaptable, non-viral approaches to CAR TCR methodologies
August 04, 2020 11:00 AM EDT

View this webinars

Scalable Manufacturing and Nanovesicle Delivery of CRISPR-Cas9 Ribonucleoproteins Using a cGMP- Compliant Cell Engineering Platform
September 17, 2020 8:00 AM PT

View this webinar

Dr. Mark DeWitt, a leading industry expert, shares his secrets on success with the development of a CRISPR/Cas9-based strategy
October 15, 2020 11:00 AM EDT

View this webinar

Webinars

Winning the Race: Decreasing Protein Development Timelines with Scalable Cell-Engineering
April 15, 2019

Latest Industry News

BIO CEO Defends Dr. Fauci, Says Criticisms “Undermine Our Response to this Pandemic”

In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement:”

July 16, 2020

STAT: First Opinion

A new biotechnology and pharmaceutical industry commitment to patients and the public.

January 8, 2020

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018.

February 25, 2019

BIO’s Workforce Development, Diversity & Inclusion Principles

MaxCyte has committed itself to fostering workplace development, diversity, and inclusion (WDDI) at MaxCyte and across the biotechnology industry. We are dedicated to being at the forefront of efforts to develop a diverse and talented global workforce. To that end, we affirmatively support the following WDDI Principles adopted by the Biotechnology Innovation Organization (BIO), and pledge to do our part to foster diversity and inclusion among our employees, customers, and patients.

February 6, 2018

BIO News: Champion the Biotechnology Industry

See BIO’s latest periodic updates on key issues facing the advancement of science and the ability of researchers and entrepreneurs to deliver the latest medical and biological breakthroughs to people who need them around the world.

July 26, 2017

BIO News: Saving Lives & Transforming Healthcare in the 21st Century

Learn about the impact of biotechnology on patients and society, as well as the factors needed to keep the innovation engine running strong.

April 7, 2017

Twitter Feed News


MaxCyte will be at #ASGCT21 May 11-14! Visit our booth to learn more about ExPERT™, the industry's leading, clinically validated and scalable #electroporation technology and our Industry Symposium presentation May 11 from 2:00-3:30pm. https://t.co/oMU3cFsLSr #GoldSponsor https://t.co/qQYdNXnDad MaxCyte_info photo

Congratulations to our partner, @CRISPRTX on the PRIME designation by the European Medicines Agency for their investigational #CRISPR/Cas9 #GeneEditing program for transfusion-dependent #BetaThalassemia: https://t.co/DhmnPzQGoP
@EMA_News @VertexPharma #CTX001

MaxCyte will be at #Cellicon21 May 6-7. Visit our booth and learn about ExPERT, the industry's leading clinically-validated and scalable technology for complex #CellularEngineering.
https://t.co/jcqutU7oMj

#CARTcell #MyExpertPlatform #CellTherapy https://t.co/ShPZBRiUhb
MaxCyte_info photo

MaxCyte will be at #ASGCT21 May 11-14! Visit our booth to learn more about ExPERT™, the industry's leading, clinically validated and scalable #electroporation technology and our Industry Symposium presentation May 11 from 2:00-3:30pm. https://t.co/oMU3cFsLSr #GoldSponsor https://t.co/UqGaKhEJG6 MaxCyte_info photo

Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter

Sign Up